MA43703A - COMPOSITIONS AND METHODS FOR INCREASING IRON ABSORPTION IN A MAMMAL - Google Patents

COMPOSITIONS AND METHODS FOR INCREASING IRON ABSORPTION IN A MAMMAL

Info

Publication number
MA43703A
MA43703A MA043703A MA43703A MA43703A MA 43703 A MA43703 A MA 43703A MA 043703 A MA043703 A MA 043703A MA 43703 A MA43703 A MA 43703A MA 43703 A MA43703 A MA 43703A
Authority
MA
Morocco
Prior art keywords
mammal
compositions
methods
iron absorption
increasing iron
Prior art date
Application number
MA043703A
Other languages
French (fr)
Inventor
Radics Gabor
John Gilmer
Mark Ledwidge
Pat O'flynn
Jun Wang
Michael Whelehan
Original Assignee
Solvotrin Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvotrin Therapeutics Ltd filed Critical Solvotrin Therapeutics Ltd
Publication of MA43703A publication Critical patent/MA43703A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
MA043703A 2016-03-15 2017-03-15 COMPOSITIONS AND METHODS FOR INCREASING IRON ABSORPTION IN A MAMMAL MA43703A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16160539 2016-03-15

Publications (1)

Publication Number Publication Date
MA43703A true MA43703A (en) 2018-11-28

Family

ID=55640537

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043703A MA43703A (en) 2016-03-15 2017-03-15 COMPOSITIONS AND METHODS FOR INCREASING IRON ABSORPTION IN A MAMMAL

Country Status (28)

Country Link
US (1) US11224615B2 (en)
EP (1) EP3429560A1 (en)
JP (1) JP7193145B2 (en)
KR (1) KR102403292B1 (en)
CN (1) CN109069430B (en)
AU (1) AU2017232266B2 (en)
BR (1) BR112018068571A2 (en)
CA (1) CA3017556C (en)
CL (1) CL2018002632A1 (en)
CO (1) CO2018010940A2 (en)
CR (1) CR20180488A (en)
CU (1) CU20180108A7 (en)
EA (1) EA201892065A1 (en)
EC (1) ECSP18077068A (en)
GE (1) GEP20227445B (en)
IL (1) IL261735B (en)
MA (1) MA43703A (en)
MX (1) MX2018011227A (en)
MY (1) MY196575A (en)
NI (1) NI201800089A (en)
NZ (1) NZ747227A (en)
PE (1) PE20181955A1 (en)
PH (1) PH12018501994A1 (en)
SA (1) SA518400019B1 (en)
SG (1) SG11201807985XA (en)
UA (1) UA125211C2 (en)
WO (1) WO2017158030A1 (en)
ZA (1) ZA201806814B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114027507B (en) * 2021-11-18 2023-02-28 中国农业大学 Oral gel iron supplement and preparation method thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US505986A (en) 1893-10-03 Pio marfori
US4167564A (en) 1974-09-23 1979-09-11 Albion Laboratories, Inc. Biological assimilation of metals
US4067994A (en) 1976-03-26 1978-01-10 Zinpro Corporation Iron methionine complex salts
US4216144A (en) 1977-10-20 1980-08-05 Ashmead H H Soluble iron proteinates
IT1150213B (en) 1982-03-02 1986-12-10 Italfarmaco Spa BIOAVAILABLE IRON DERIVATIVES FREE FROM GASTROLESIVITY, PREPARATION PROCEDURE AND RELATED PHARMACEUTICAL COMPOSITIONS
IT1186787B (en) 1985-11-06 1987-12-16 Mediolanum Farmaceutici Srl IRON-DERIVATIVES OF GLOBIN AND ACETYLGLOBIN EQUIPPED WITH HIGH BIOAVAILABILITY, PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS
US5418010A (en) 1990-10-05 1995-05-23 Griffith Laboratories Worldwide, Inc. Microencapsulation process
JP3404294B2 (en) * 1998-08-11 2003-05-06 雪印乳業株式会社 Iron-whey protein hydrolyzate complex
US6521247B1 (en) 1999-08-13 2003-02-18 Warner Chilcott Laboratories Ireland Limited Dual iron containing nutritional supplement
WO2005041677A1 (en) * 2003-10-30 2005-05-12 Arla Foods Amba Stabilisers useful in low fat spread production
CN1557481A (en) 2004-02-04 2004-12-29 高春平 Natural nutrient for preventing and treating iron-deficiency anemia
US20060134227A1 (en) 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
US7585527B2 (en) 2005-09-19 2009-09-08 Bala Venkataraman Composition and method for treating iron deficiency anemia
WO2008022932A2 (en) * 2006-08-25 2008-02-28 Boehringer Ingelheim International Gmbh Controlled release system and method for manufacturing the same
CN101143011B (en) 2007-10-09 2011-06-22 浙江大学 Method for improving iron bioavailability in food
US20090124572A1 (en) 2007-11-09 2009-05-14 Deanna Jean Nelson Iron-containing nutritional supplement
CN101928742B (en) 2009-06-23 2013-02-27 光明乳业股份有限公司 Whey protein active peptide with antioxidant activity and preparation method thereof
WO2012097155A1 (en) 2011-01-14 2012-07-19 Chiasma Inc. Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
DK2731450T3 (en) 2011-07-15 2016-01-11 Nestec Sa WRAPPED FOOD AND PROCEDURE FOR ITS PREPARATION
AU2012311964B2 (en) * 2011-09-22 2016-09-22 Amip Buffered upper GI absorption promoter
WO2014148886A1 (en) 2013-03-22 2014-09-25 N.V. Nutricia Fermented nutrition high in lactose with increased iron bioavailability
GB201416293D0 (en) * 2014-09-15 2014-10-29 Solvotrin Therapeutics Ltd Methods and preparations
EP2995205A1 (en) * 2014-09-15 2016-03-16 Anabio Technologies Limited Compositions and methods for the maintenance of adequate iron intake in a mammal

Also Published As

Publication number Publication date
KR20190006946A (en) 2019-01-21
CL2018002632A1 (en) 2019-03-15
AU2017232266B2 (en) 2022-10-06
IL261735A (en) 2018-10-31
US20190054115A1 (en) 2019-02-21
MX2018011227A (en) 2019-05-16
UA125211C2 (en) 2022-02-02
NZ747227A (en) 2022-11-25
MY196575A (en) 2023-04-19
IL261735B (en) 2022-07-01
JP2019511572A (en) 2019-04-25
KR102403292B1 (en) 2022-05-27
PH12018501994A1 (en) 2019-06-17
PE20181955A1 (en) 2018-12-17
EP3429560A1 (en) 2019-01-23
BR112018068571A2 (en) 2019-04-16
SG11201807985XA (en) 2018-10-30
CN109069430A (en) 2018-12-21
ZA201806814B (en) 2021-03-31
JP7193145B2 (en) 2022-12-20
SA518400019B1 (en) 2022-12-11
WO2017158030A1 (en) 2017-09-21
ECSP18077068A (en) 2018-12-31
CN109069430B (en) 2022-09-23
CR20180488A (en) 2019-03-12
AU2017232266A1 (en) 2018-11-08
CU20180108A7 (en) 2019-09-04
NI201800089A (en) 2019-05-16
GEP20227445B (en) 2022-12-12
US11224615B2 (en) 2022-01-18
CO2018010940A2 (en) 2018-11-22
CA3017556C (en) 2023-12-05
EA201892065A1 (en) 2019-04-30
CA3017556A1 (en) 2017-09-21

Similar Documents

Publication Publication Date Title
MA45670A (en) PROCESSES, COMPOSITIONS AND KITS TO INCREASE GENOME EDITING EFFICIENCY
EP3468349A4 (en) Methods for identifying crosses for use in plant breeding
HUE054783T2 (en) Pridopidine in treating huntington's disease
ZA201406209B (en) Methods and compositions for treating huntington's disease
IL239961A0 (en) Diagnostically useful results in real time
BRPI0819331A2 (en) Methods and compositions for treating dry eye
EP2760894A4 (en) Photo-curable composition and patterning method using the same
BR112015011777A2 (en) synergistic mixtures, kit, pesticide composition, method for the protection of plant propagating material and plant propagating material.
HK1218129A1 (en) Method and kit for detecting 1,25-dihydroxyvitamin d and related antibodies 125- d
MA41296A (en) TRANSDIFFERENTIATION PROCESSES AND METHODS FOR USING THE SAME
PL2688055T3 (en) Machine that simulates the movement produced during transport
IL251240A0 (en) Defect reduction methods and composition for via formation in directed self-assembly patterning
IL251193A0 (en) Compositions and methods for increasing iron intake in a mammal
EP2978446A4 (en) Methods and agents for treating alzheimer's disease
FR2994481B1 (en) METHOD FOR CHARACTERIZING AN OBJECT IN COMPOSITE MATERIAL
MA43703A (en) COMPOSITIONS AND METHODS FOR INCREASING IRON ABSORPTION IN A MAMMAL
FI20136222A (en) Apparatus for influencing the material to be transferred in the material transfer channel
SE1651558A1 (en) A measuring device and a method for measuring play in a balljoint
FR2988486B1 (en) METHOD FOR STUDYING THE MULTI-LINEAR ATMOSPHERE
FR3042869B1 (en) METHOD FOR CHARACTERIZING AN OBJECT IN COMPOSITE MATERIAL
DE112012005310A5 (en) Method for determining a particle property and for classifying a particle charge and device for carrying out the method
FR2989901B1 (en) LAUNCHING DEVICE FOR FLYERS AND THE LIKE, IN PARTICULAR THE BADMINTON GAME TRAINING
DE602009000278D1 (en) Device for automatically straightening postal articles
BR112014032456A2 (en) in vitro methods, pharmaceutical composition, method kit and method for improving the treatment effect
FR2978306B1 (en) INSERT WITH POINTS AND DEVICE IMPLEMENTING THE INSERT